Skip to content

APOTHEEK LEEMPUT

Active Private limited companyfounded 2021active for 5 yearsSint-Truidensesteenweg 188, 3350 LinterKBO/BCE: BE 0766.809.447 #9 company by equity in Linter, Wholesale and retail trade sector

Lifetime

5 annual accounts with figures on one time axis
peak of €300,233 in 2025
€300,233▲ 14.8%
peak of €154,857 in 2025
€154,857▲ 15.8%
peak of €536,183 in 2025
€536,183▲ 19.3%
€113,706▲ 23.6%
peak of 0.5 FTE in 2022
0.4 FTEunchanged
Board1 name since 2021
1 director
Documentsfilings and deeds
22-07-20269 days before the deadline
2025abbreviated format
Gross margin from €261,481 to €300,233Dividend €68,069Equity from €449,396 to €536,183Debts from €91,973 to €113,706Cash from €189,203 to €281,087

Key points

from the 2025 annual accounts

Equity

€536,183 ▲ 19.3%
449,3962024+154,857Profit-68,069Dividend536,1832025

APOTHEEK LEEMPUT paid out €68,069 in dividends. That is 44% of the 2025 profit.

Filings

5 annual accounts 3 late
AprilJune31 JulyOctober20222024

The 2021 accounts came in latest, 31 days after the end of the period.

Position in the sector

82.5%

Higher solvency than 91% of companies in retail trade. The sector median is 36.9%, over 13,289 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as APOTHEEK LEEMPUT has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for APOTHEEK LEEMPUT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 16-04-2021
  • 100 sharesdeed of 20-04-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0766809447
Incorporation Founding capital of €3,000, 100 shares · Founded by · appointed as director · published on 20-04-2021 · Gazette deed
First establishment Sint-Truidensesteenweg 188, Linter
All 13 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK LEEMPUT Linter €649,890 €300,233 82.5% 0.4
APOTHEEK ANN-SOPHIE COPPIN Knokke-Heist €845,739 €250,018 27.7% 0.6
Pharma Poperinge Ghent €898,903 €298,760 4.9% 0.7
Boskant Merchtem €729,117 €192,684 69.3% 0.2
APOTHEEK AELTERMAN L. Halle €632,353 €224,136 36.5% 0
3-FOLIA Ghent €696,291 €288,415 31.1% 0.8
Apotheek Thewissen Heist-op-den-Berg €911,253 €272,980 47.5% 0.6

These companies have the same main activity as APOTHEEK LEEMPUT: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €632,000 and €911,000, founded between 2018 and 2020.

Official details

Source: KBO
Status
Active since 16-04-2021Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2024
Establishment unit
2.315.977.6413350 Linter, since 16-04-2021
Financial year end
31 December
Peppol
Reachable since 28-08-2025
Company details

Annual accounts 2025

≈ €1.0mestimated
€649,890▲ 20.0%
Employeeson 31-12-2025
1=
Filing
Filed on 22-07-2026, 9 days before the end of the filing period
Financials

Insights on APOTHEEK LEEMPUT

APOTHEEK LEEMPUT files the abbreviated format. That format states no turnover. The gross margin rose from €138,777 in 2021 to €300,233 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK LEEMPUT

What is the company number of APOTHEEK LEEMPUT?
The company number of APOTHEEK LEEMPUT is 0766.809.447. The VAT number is the same number with BE in front: BE 0766.809.447.
Where is APOTHEEK LEEMPUT based?
The registered office is at Sint-Truidensesteenweg 188, 3350 Linter.Company details
What does APOTHEEK LEEMPUT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK LEEMPUT?
APOTHEEK LEEMPUT is a private limited company (BV).
When was APOTHEEK LEEMPUT founded?
APOTHEEK LEEMPUT was founded on 16-04-2021.
Is APOTHEEK LEEMPUT still active?
Yes, APOTHEEK LEEMPUT is an active enterprise in the KBO register.
How many employees does APOTHEEK LEEMPUT have?
APOTHEEK LEEMPUT had an average of 0.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK LEEMPUT fall under?
In its 2024 annual accounts, APOTHEEK LEEMPUT states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK LEEMPUT?
The turnover in financial year 2025 is about €1.0m. This figure is estimated from the gross margin of €300,233 and 42 comparable companies (NACE 477). It probably lies between €810,000 and €1.4m.
Is APOTHEEK LEEMPUT profitable?
In financial year 2025, APOTHEEK LEEMPUT made a profit of €154,857.
Where can I find the annual accounts of APOTHEEK LEEMPUT?
APOTHEEK LEEMPUT filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK LEEMPUT due?
APOTHEEK LEEMPUT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.